Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002040586-24-000001
Filing Date
2024-10-17
Accepted
2024-10-16 18:52:53
Documents
1
Effectiveness Date
2024-10-17
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8631
  Complete submission text file 0002040586-24-000001.txt   9790
Mailing Address 27 FITZROY SQUARE LONDON X0 W1T 6ES
Business Address 27 FITZROY SQUARE LONDON X0 W1T 6ES 44 020 7932 2120
Advent Life Sciences Growth Fund LP (Filer) CIK: 0002040586 (see all company filings)

EIN.: 981813752 | State of Incorp.: X0
Type: D | Act: 33 | File No.: 021-527005 | Film No.: 241375649